MnFe2O4 nanoparticles accelerate the clearance of mutant huntingtin selectively through ubiquitin-proteasome system. (September 2019)

• Record Type: Journal Article
• Authors: Zhang, Li; Wei, Peng-Fei; Song, Yong-Hong; Dong, Liang; Wu, Ya-Dong; Hao, Zong-Yao; Fan, Song; Tai, Sheng; Meng, Jia-Lin; Lu, Yang; Xue, Jingzhe; Liang, Chao-Zhao; Wen, Long-Ping
• Is Part Of: Biomaterials. Volume 216(2019)
• Publication Date: 2019-09
• Subjects: MnFe2O4 nanoparticles -- Huntington's disease -- Polyglutamine -- Ubiquitin-proteasome system -- Autophagy-lysosomal pathway; Biomedical materials -- Periodicals; Biocompatible Materials -- Periodicals; Biomatériaux -- Périodiques; 610.28
• DOI: 10.1016/j.biomaterials.2019.119248
• Languages: English
• ISSNs: 0142-9612

Abstract

Abstract: Neurodegenerative disorders such as Huntington's disease (HD) are fundamentally caused by accumulation of misfolded aggregate-prone proteins. Previous investigations have shown that these toxic protein aggregates could be degraded through autophagy induced by small molecules as well as by nanomaterials. However, whether engineered nanomaterials have the capacity to degrade these protein aggregates via the ubiquitin-proteasome system (UPS), the other major pathway for intracellular protein turnover, was unknown. Herein, we have synthesized biocompatible MnFe2 O4 nanoparticles (NPs) and demonstrated their unique effect in accelerating the clearance of mutant huntingtin (Htt) protein exhibiting 74 glutamine repeats [Htt(Q74)]. UPS, rather than autophagy, was responsible for the efficient Htt(Q74) degradation facilitated by MnFe2 O4 NPs. Meanwhile, we demonstrated that MnFe2 O4 NPs enhanced K48-linked ubiquitination of GFP-Htt(Q74). Moreover, ubiqinlin-1, but not p62/SQSTM1, served as the ubiquitin receptor that mediated the enhanced degradation of Htt(Q74) by MnFe2 O4 NPs. Our findings may have implications for developing novel nanomedicine for the therapy of HD and other polyglutamine expansion diseases.